ArticleOncoimmunology2020
Progesterone receptor promotes degradation of STAT2 to inhibit the interferon response in breast cancer.
Katherine R Walter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it